Literature DB >> 21736606

Dyskeratosis congenita--two siblings with a new missense mutation in the DKC1 gene.

Joana Dias Coelho1, Sara Lestre, Teresa Kay, Maria João Paiva Lopes, Teresa Fiadeiro, Margarida Apetato.   

Abstract

Dyskeratosis congenital is reported in two siblings. They presented with the classic triad of mucocutaneous features: leukoplakia of the tongue, dystrophic nails, and a widespread reticulate pigmentation on the neck and upper chest. A genetic analysis was performed and a new missense mutation S356P, hemizygous, was identified in the DKC1 gene in both patients. Acitretin was started at a low-dose in both patients, resulting in clinical improvement and important, positive psychosocial effects.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21736606     DOI: 10.1111/j.1525-1470.2010.01299.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

Review 1.  Common dermatologic manifestations of primary immune deficiencies.

Authors:  Manisha Relan; Heather K Lehman
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.919

2.  Clinical heterogeneity in a family with DKC1 mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins.

Authors:  Cristina Olivieri; Anna Mondino; Matteo Chinello; Alessandra Risso; Enrico Finale; Marina Lanciotti; Andrea Guala
Journal:  Pediatr Rep       Date:  2017-10-06

3.  Case Report: A Missense Mutation in Dyskeratosis Congenita 1 Leads to a Benign Form of Dyskeratosis Congenita Syndrome With the Mucocutaneous Triad.

Authors:  Liqing Wang; Jianwei Li; Qiuhong Xiong; Yong-An Zhou; Ping Li; Changxin Wu
Journal:  Front Pediatr       Date:  2022-04-06       Impact factor: 3.418

Review 4.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.